🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
Baricitinib a selective Janus kinase (JAK) inhibitors 1\&2 have been recogn...
Status
Unknown
Location
Manal Hassanien
Start Date
2022-06-01
Trial ID
NCT05686746
Treatments Being Tested
Dermatomyositis (DM) is a rare and disabling condition with an important im...
Status
Recruiting
Location
Pitie-Salpêtrière hospital APHP
Start Date
2022-08-31
Trial ID
NCT04972760
Treatments Being Tested
There is urgent need of an effective therapy for Covid-19. To date, the bes...
Status
Unknown
Location
Azienda Ospedaliero Universitaria Pisana
Start Date
2020-05-20
Trial ID
NCT04393051
Treatments Being Tested
The purpose of the present study is to study the effect of baricitinib admi...
Status
Recruiting
Location
Tandu Hospital, Fourth Military Medical University
Start Date
2023-11-24
Trial ID
NCT06065046
Treatments Being Tested
This is a randomized controlled study. Baricitinib 4mg in one arm and Baric...
Status
Completed
Location
Dr. Md. Sadikul islam
Start Date
2022-10-01
Trial ID
NCT05660655
Treatments Being Tested
An Open-Label, Proof-Of-Concept, Study of Baricitinib for the Treatment of ...
Status
Completed
Location
Oregon Health and Science University
Start Date
2023-10-03
Trial ID
NCT04901325
Treatments Being Tested
The purpose of this study is to evaluate the efficacy and safety of baricit...
Status
Completed
Location
CENIT Centro de Neurociencias, Investigación y Tratamiento
Start Date
2017-11-27
Trial ID
NCT03334422
Treatments Being Tested
This is an open-label, biomarker-driven basket trial of baricitinib in peop...
Status
Completed
Location
Massachusetts General Hospital - ALS Site
Start Date
2022-12-05
Trial ID
NCT05189106
Treatments Being Tested
This post-marketing study is designed to compare the safety of baricitinib ...
Status
Completed
Location
Arizona Arthritis & Rheumatology Research, PLLC
Start Date
2019-04-25
Trial ID
NCT03915964
Treatments Being Tested
Takayasu arteritis (TKA) is an autoimmune vasculitis characterized with inv...
Status
Completed
Location
Department of Rheumatology and Immunology, Peking University People's Hospital
Start Date
2023-04-03
Trial ID
NCT06662721
Treatments Being Tested